[1] Christian Trautwein, Scott L. Friedman, Detlef Schuppan, et al. Hepatic fibrosis: Concept to treatment. Journal ofhepatology[J]. 2015, 62(1 Suppl): 15-24.
[2] 吴先闯, 杜钢军. 灯盏花素抗纤维化和抗肿瘤作用研究[D]. 开封:河南大学,2010.
[3] 林明华, 孟庆媛, 郭梦凡. 灯盏花素干预大鼠肝星状细胞Caspase-3、NF-κB表达的研究[J]. 黑龙江医药科学, 2012, 35(5): 46-48.
[4] 王银辉, 耿玲, 李辉. 灯盏乙素抗大鼠肝纤维化作用的研究[J]. 中国中药杂志, 2015, 40(10): 1999-2003.
[5] 孟庆媛, 苏亚楠, 郭梦凡,等. 灯盏花素对肝纤维化模型大鼠MMP-13及TIMP-1表达的研究[J]. 黑龙江医药科学, 2013, 36(3): 96-97.
[6] Cornel Balta, Hildegard Herman a, Oana Maria Boldura, et al. Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway[J]. Chemico-Biological Interactions, 2015, 240: 94-101.
[7] Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepaticfibrosis[J]. Gut, 2005, 54(1): 142-151.
[8] Hideaki Shimada,Nicholas R.Staten,Lakshman E. Rajagopalan, et al. TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells[J]. Journal of Hepatology, 2011, 54(3): 521-528.
[9] Marco Trappoliere, Alessandra Caligiuri1, Monika Schmid, et al. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells[J]. Journal of Hepatology, 2009, 50(6): 1102-1111.
[10] 侯凌波, 乔利军, 郭建文. 灯盏细辛注射液对血瘀型急性脑梗死患者血清VEGF、MMP-9、EPCs水平的影响[J]. 中成药, 2015, 37(11): 2373-2378.
[11] 周峰. 灯盏花素注射液治疗急性脑梗死30例[J]. 河南中医,2015, 35(9): 2095-2096.
[12] 黄振坚, 何世安, 雷斌. 急性脑梗死灯盏花、芎嗪注射液联合血塞通治疗的临床分析[J]. 中药材, 2014, 37(6): 1110-1113.
[13] PAN E, ZHAO W, ZHANG X, et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2[J]. Br J Pharmacol, 2011, 162(3): 688-700.
[14] Virginia Hernandez-Gea,Scott L. Friedman. Pathogenesis of Liver Fibrosis[J].Annual Review of Pathology: Mechanisms of Disease, 2011,(6): 425-456.
[15] Zhiwen Fan, Chenzhi Hao, Min Li, et al. MKL1 is an epigenetic modulator of TGF-β inducedfibrogenesis[J]. Biochimica et Biophysica Acta, 2015, 1849(9): 1219-1228.
[16] Ming-Yi Xu, Jun-Jie Hu, Jie Shen, et al. Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury andfibrosis[J]. Biochimica et Biophysica Acta, 2014, 1842(11): 2237-2245.
[17] Ling Fang, Cheng Huang, Xiaoming Meng, et al. TGF-β1 elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway[J]. Toxicology and Applied Pharmacology, 2014, 280(2): 335-344.
[18] Jin Won Yang, Tran Thi Hien, Sung Chul Lim, et al. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation[J]. Journal of Hepatology, 2014, 60(6): 1235-1241.
[18] Y. Jiang, C. Wang, Y.Y. Li, et al. Mistletoe alkaloid fractions alleviates carbon tetrachloride- induced liverfibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference[J]. J Ethnopharmacol, 2014, 158Pt A: 230-238.
[20] Lingyuan Xu, Ni Zheng, Qiaoling He, et al. Puerarin, isolated from Pueraria lobata(Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect[J]. Phytomedicine, 2013, 20(13): 1172-1179.
[21] J.H. Lee, E.J. Jang, H.L. Seo, et al. Sauchinone attenuates liverfibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway[J]. Chem Biol Interact, 2014, 224C: 58-67.